Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2203)
All Articles published online
|
Oct 21, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Watson NF, Durrant LG, Scholefield JH, Madjd Z, Scrimgeour D, Spendlove I, Ellis IO, Patel PM. Cytoplasmic expression of p27kip1 is associated with a favourable prognosis in colorectal cancer patients. World J Gastroenterol 2006; 12(39): 6299-6304 [PMID: 17072952 DOI: 10.3748/wjg.v12.i39.6299] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i39/6299.htm |
| Number | Citing Articles |
| 1 |
Timothy J. Duncan, Ahmad Al-Attar, Phil Rolland, Sarah Harper, Ian Spendlove, Lindy G. Durrant. Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer. International Journal of Gynecological Pathology 2010; 29(1): 8 doi: 10.1097/PGP.0b013e3181b64ec3
|
| 2 |
Shuji Ogino, Kaori Shima, Katsuhiko Nosho, Natsumi Irahara, Yoshifumi Baba, Brian M. Wolpin, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Charles S. Fuchs. A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival. Cancer Epidemiology, Biomarkers & Prevention 2009; 18(6): 1849 doi: 10.1158/1055-9965.EPI-09-0181
|
| 3 |
Dan D Hershko. Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target. Future Oncology 2010; 6(12): 1837 doi: 10.2217/fon.10.144
|
| 4 |
Isabel M. Chu, Ludger Hengst, Joyce M. Slingerland. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature Reviews Cancer 2008; 8(4): 253 doi: 10.1038/nrc2347
|
| 5 |
Roger W. McGilvray, Robert A. Eagle, Nicholas F.S. Watson, Ahmad Al-Attar, Graham Ball, Insiya Jafferji, John Trowsdale, Lindy G. Durrant. NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting. Clinical Cancer Research 2009; 15(22): 6993 doi: 10.1158/1078-0432.CCR-09-0991
|
| 6 |
Tai-Yu Lai, Chia-Jui Yen, Hung-Wen Tsai, Yu-San Yang, Wei-Fu Hong, Chi-Wu Chiang. The B56γ3 regulatory subunit-containing protein phosphatase 2A outcompetes Akt to regulate p27KIP1 subcellular localization by selectively dephosphorylating phospho-Thr157 of p27KIP1. Oncotarget 2016; 7(4): 4542 doi: 10.18632/oncotarget.6609
|
| 7 |
Adriana Borriello, Debora Bencivenga, Maria Criscuolo, Ilaria Caldarelli, Valeria Cucciolla, Annunziata Tramontano, Alessia Borgia, Annamaria Spina, Adriana Oliva, Silvio Naviglio, Fulvio Della Ragione. Targeting p27Kip1protein: its relevance in the therapy of human cancer. Expert Opinion on Therapeutic Targets 2011; 15(6): 677 doi: 10.1517/14728222.2011.561318
|
| 8 |
NEVYANA R. HRISTOVA, KATRIN E. TAGSCHERER, ANNE FASSL, JUERGEN KOPITZ, WILFRIED ROTH. Notch1-dependent regulation of p27 determines cell fate in colorectal cancer. International Journal of Oncology 2013; 43(6): 1967 doi: 10.3892/ijo.2013.2140
|
| 9 |
Jackie L. Ha, Erin Kaser, Tianyun Guan, Trenton G. Mayberry, Luke A. Smith, Kyle D’mello, Qian Bai, Mark R. Wakefield, Lijun Dong, Yujiang Fang. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1. Medical Oncology 2024; 41(3) doi: 10.1007/s12032-023-02276-3
|